RPL24P2

Across TCGA pan-cancer cohorts, RPL24P2 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated RPL24P2 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher RPL24P2 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RPL24P2 expression acts as an unfavorable survival marker, although some lineages such as UVM and ESCA show a favorable association.

UVM, ACC, and LUAD are the cancer types where RPL24P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Quartile	II,III,IV	0.933	0.358	<.001	61	view →
ACC	DFS	Quartile	II,III,IV	0.333	0.751	.001	32	view →
LUAD	OS	Quartile	III,IV	0.261	0.767	<.001	27	view →
LIHC	OS	Tertile	III,IV	0.546	0.759	.013	23	view →
PAAD	DFS	Quartile	All	0.440	0.633	.016	20	view →
ESCA	OS	Median	IV	0.743	0.290	.013	18	view →
SKCM	DFS	Quartile	II,III,IV	0.168	0.450	<.001	12	view →
OV	OS	Median	All	0.287	0.354	.031	12	view →
COAD	DFS	Tertile	All	0.675	0.430	.014	11	view →
LUSC	OS	Tertile	All	0.508	0.364	.019	10	view →
UCEC	OS	Tertile	IV	0.317	0.701	.030	8	view →
DLBC	DFS	Quartile	IV	0.282	1.000	.038	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

RPL24P2–UVM (DFS)

Open the UVM breakdown →